Cross-border use issue
G_CROSS_BORDERWhat does this word mean?
The fact that a product is legal in its home country and whether it can legally be used in another country are two independent questions.
Expanded note
This is the item most often skipped in regulatory content yet the most valuable to readers. Korean Rejuran and Italian Placentex completed drug or device registration in their own countries, which does not mean they can legally be used elsewhere, and the fact that a Korean brand is purchasable through cross-border e-commerce does not mean it qualifies for lawful sale inside China. Whenever the site covers cross-border content it must separate registration-status-in-the-origin-country from legality-in-the-country-of-use.
Not a generic example.
Cross-border use and local cosmetic use are two separate legal questions: approval in one jurisdiction does not carry over to another.
Related terms
Where this term appears
Educational reference only. This site does not provide medical advice, treatment courses, injection counts, clinic recommendations or price recommendations.
PDRN is not approved by the FDA for injection or any therapeutic use. Topical and injectable PDRN are parallel facts under different regulatory pathways and must not be directly equated.
PN is not PDRN. Evidence grades are labelled on every factual element; in vitro and animal research is never described as clinical efficacy.